Back to Journals » Blood and Lymphatic Cancer: Targets and Therapy
Blood and Lymphatic Cancer: Targets and Therapy
Editor-in-Chief: Dr Wilson Gonsalves
An international, peer reviewed, open access journal focusing on blood and lymphatic cancer research, identification of therapeutic targets, and the optimal use of preventative and integrated treatment interventions to achieve improved outcomes, enhanced survival, and quality of life for the cancer patient.
The journal welcomes submitted papers covering original research, basic science, clinical & epidemiological studies, reviews & evaluations, guidelines, expert opinion and commentary, case reports, and extended reports.
This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE).
Articles:
- View all (146)
- Volume 16, 2026 (20)
- Volume 15, 2025 (19)
- Volume 14, 2024 (6)
- Volume 13, 2023 (7)
- Volume 12, 2022 (12)
- Volume 11, 2021 (6)
- Volume 10, 2020 (2)
- Volume 9, 2019 (7)
- Volume 8, 2018 (7)
- Volume 7, 2017 (8)
- Volume 6, 2016 (5)
- Volume 5, 2015 (11)
- Volume 4, 2014 (13)
- Volume 3, 2013 (6)
- Volume 2, 2012 (12)
- Volume 1, 2011 (5)
Latest articles:
- 5 records -
Efficacy and Safety of CLAG-Based Sequential Conditioning Followed by Allogeneic Hematopoietic Stem Cell Transplantation in Non-Remission Relapsed or Refractory Acute Leukemia
Chen S, Zhang X, Li X, Du X
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:601808
Published Date: 27 July 2026
Long-Term Results of Busulfan Plus High-Dose Idarubicin as a Conditioning Regimen to Autologous Stem Cell Transplantation Following Cytarabine Consolidation in Young Patients with Favorable or Intermediate-Risk Acute Myeloid Leukemia
Lu Z, Liu Y, Jiang Z, Zhu Y, Liu W, Sun Q, Fan L, Qian S, Hong M
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:621412
Published Date: 15 July 2026
Risk and Survival Outcomes of Secondary Primary Malignancies in Chinese Lymphoma Patients in the Era of Modern Targeted Therapies: A Single-Center Retrospective Cohort Study
Qiu C, Zhang T, Yang X, Guo Y, Gong Z, Song D
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:616235
Published Date: 14 July 2026
Metabolic Subtypes Predict Treatment Response in Acute Myeloid Leukemia: A Pilot Study
Yan C, Huang Y, Cai Q, Li X, Yang Q, Feng G, Yang H, Chen Y, Hu J
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:612305
Published Date: 16 June 2026
A Risk Model Using Refined Disease Risk Index and 1-Month NK-Cell Count for Relapse in Children and Adults with T-ALL/LBL After Myeloablative Umbilical Cord Blood Transplantation
Zhao N, Chi R, Song K, Wu Y, Yan B, Wang D, Tang B, Zhu X
Blood and Lymphatic Cancer: Targets and Therapy 2026, 16:582933
Published Date: 22 May 2026